August 28, 2018
August 28, 2018
February 14, 2013
A new blood test, which has the potential to accurately diagnose Alzheimerās disease in individuals and significantly advance drug testing and research on the disease, has been developed through grant funding by Cure Alzheimer’s Fund.Ā The test, known as Immunosignature (IS) and developed by a team led by UCLA neurologist Lucas ...
April 28, 2014
Last week, Cure Alzheimerās Fund Research Consortium chairman Rudy Tanzi was featured on NOVA in a segment concerning genetic testing. The special followed several cases of people affected by genetic testing, showing both its benefits and challenges. NOVA only briefly touched on Alzheimerās disease, but provided a comprehensive explanation of ...
April 4, 2012
A NYT article about the value of using spinal fluid tests to determine the presence of Alzheimerās disease is optimistic and hopeful but maybe too much so. In an article published yesterday, Gina Kolata writes āResearchers are finding simple and accurate ways to detect Alzheimerās long before there are definite ...
August 11, 2010
Rudolph E. Tanzi, Ph.D., Joseph P. and Rose F. Kennedy Professor of Neurology, Harvard Medical School; Director, Genetics and Aging Research Unit, Massachusetts General Hospital Ā The four known Alzheimerās genes. Over the past several decades, it has become increasingly clear that inheritance plays a major role in Alzheimerās disease. The roughly 25,000 ...
July 14, 2011
With a simple at-home genetics test, some people are learning they have a higher risk of Alzheimerās. Can they do anything to prevent the disease? By Sumathi Reddy Updated July 15, 2019 9:14 am ET When Theresa Braymer canāt remember a word or name, she sometimes second-guesses herself. At 59, she is young to ...
October 6, 2019
Below is the text from an article included on the Eureka blog which provides an overview of the need for a multi-pronged approach to stopping Alzheimer’s disease. The work of Dr.’s Rudy Tanzi and David Holtzman, and the late Stephen Wagner, of the Cure Alzheimer’s Fund Research Leadership Group, is ...
November 2, 2023
NY Times online columnist David Bornstein examines how the Cure Alzheimer’s Fund and other organizations have taken a unique approach to research that is intensely goal-directed and collaborative, focusing on the creation of new cures and potential treatment as a process that needs to be managed. Bornstein notes the Fund ...
May 17, 2011
2019 Alzheimerās disease is a huge health problem that imposes a severe social and economic burden; in the absence of an effective disease-modifying treatment, it is projected to become a dominant source of health care expenditures over the next several decades. Unfortunately, existing treatments are palliative, providing only temporary symptomatic benefit. ...
August 9, 2018